238 related articles for article (PubMed ID: 9774487)
1. The analgesic effects of tryptophan and its metabolites in the rat.
Heyliger SO; Goodman CB; Ngong JM; Soliman KF
Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
[TBL] [Abstract][Full Text] [Related]
2. Large amounts of picolinic acid are lethal but small amounts increase the conversion of tryptophan-nicotinamide in rats.
Shibata K; Fukuwatari T
J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):334-9. PubMed ID: 25744422
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids.
Lapin IP
J Neural Transm; 1983; 56(2-3):177-85. PubMed ID: 6864208
[TBL] [Abstract][Full Text] [Related]
4. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
Lapin IP; Ryzhov IV
Farmakol Toksikol; 1985; 48(6):13-7. PubMed ID: 3002845
[TBL] [Abstract][Full Text] [Related]
5. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
6. Complexity of in vivo induction of tryptophan oxygenase and tyrosine aminotransferase: effects of tryptophan metabolites.
Hardeland R
Comp Biochem Physiol B; 1972 Jan; 41(1):39-44. PubMed ID: 4403889
[No Abstract] [Full Text] [Related]
7. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
8. The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.
Green AR; Curzon G
Biochem Pharmacol; 1970 Jun; 19(6):2061-8. PubMed ID: 4254787
[No Abstract] [Full Text] [Related]
9. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
Jhamandas K; Boegman RJ; Beninger RJ; Bialik M
Brain Res; 1990 Oct; 529(1-2):185-91. PubMed ID: 2149296
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Möller M; Du Preez JL; Harvey BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
[TBL] [Abstract][Full Text] [Related]
11. The role of urinary tryptophan metabolites in the etiology of bladder cancer.
Bryan GT
Am J Clin Nutr; 1971 Jul; 24(7):841-7. PubMed ID: 4934541
[No Abstract] [Full Text] [Related]
12. Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry.
Naritsin DB; Boni RL; Markey SP
Anal Chem; 1995 Mar; 67(5):863-70. PubMed ID: 7762823
[TBL] [Abstract][Full Text] [Related]
13. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice.
Lapin IP
J Neural Transm; 1978; 42(1):37-43. PubMed ID: 641543
[TBL] [Abstract][Full Text] [Related]
14. Changes in membrane fluidity induced by tryptophan and its metabolites.
Rudzite V; Jurika E; Jirgensons J
Adv Exp Med Biol; 1999; 467():353-67. PubMed ID: 10721077
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
16. An expanding range of targets for kynurenine metabolites of tryptophan.
Stone TW; Stoy N; Darlington LG
Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
[TBL] [Abstract][Full Text] [Related]
18. Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway.
Narui K; Noguchi N; Saito A; Kakimi K; Motomura N; Kubo K; Takamoto S; Sasatsu M
Biol Pharm Bull; 2009 Jan; 32(1):41-4. PubMed ID: 19122278
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2
Forrest CM; Kennedy PG; Rodgers J; Dalton RN; Turner C; Darlington LG; Cobb SR; Stone TW
Neurochem Int; 2016 Nov; 100():110-119. PubMed ID: 27623092
[TBL] [Abstract][Full Text] [Related]
20. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
